Results 221 to 230 of about 16,593 (260)

A hitchhiker's guide to single‐cell epigenomics: Methods and applications for cancer research

open access: yesInternational Journal of Cancer, Volume 158, Issue 2, Page 291-304, 15 January 2026.
Abstract Genetic mutations are well known to influence tumorigenesis, tumor progression, treatment response and relapse, but the role of epigenetic variation in cancer progression is still largely unexplored. The lack of epigenetic understanding in cancer evolution is in part due to the limited availability of methods to examine such a heterogeneous ...
Marta Moreno‐Gonzalez   +2 more
wiley   +1 more source

Structure elucidation of a human melanocortin-4 receptor specific orthosteric nanobody agonist [PDF]

open access: gold
Thomas D. Fontaine   +21 more
openalex   +1 more source

Pathogenic Gαo Mutants Drive Dominant GPCR Coupling in GNAO1 Encephalopathies

open access: yesThe FASEB Journal, Volume 40, Issue 1, 15 January 2026.
Mutations in GNAO1, the gene encoding Gαo, are associated with a wide range of neurodevelopmental disorders. In this study, we show that Gαo variants linked to the most severe patient phenotypes fail to disengage from activated Gi/o‐coupled GPCRs, thereby blocking GRK‐mediated receptor phosphorylation and internalization.
Yonika A. Larasati   +4 more
wiley   +1 more source

Long-term live-cell microscopy with labeled nanobodies delivered by laser-induced photoporation

open access: yes, 2020
Boukherroub, Rabah   +12 more
core   +1 more source

Structure of beta2 adrenergic receptor bound to BI167107, Nanobody 6B9, and a positive allosteric modulator

open access: green, 2018
Xiangyu Liu   +8 more
openalex   +2 more sources

A pair of congenic mice for imaging of transplants by positron emission tomography using anti-transferrin receptor nanobodies [PDF]

open access: gold
Thomas Balligand   +11 more
openalex   +1 more source

Nanobody conjugated PLGA nanoparticles for active targeting of African Trypanosomiasis

open access: yes, 2015
Arias, JL   +7 more
core   +1 more source

Cell-specific targeting by engineered M13 bacteriophage expressing VEGFR2 nanobody.

open access: green, 2018
Farideh Ranjibar   +5 more
openalex   +2 more sources

Final specific nanobodies

open access: yes
Final specific nanobodies see description of related Work Package for further ...
openaire   +1 more source

Home - About - Disclaimer - Privacy